Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease
Clinical trial NCT07737249 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07737249
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2027-08-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.